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Abstract: Patterned hair loss (PHL) affects around 50% of the adult population worldwide.
The negative impact that this condition exerts on people’s life quality has boosted the appearance
of over-the-counter products endowed with hair-promoting activity. Nutraceuticals enriched in
polyphenols have been recently shown to promote hair growth and counteract PHL. Malus pumila
Miller cv. Annurca is an apple native to Southern Italy presenting one of the highest contents of
Procyanidin B2. We have recently shown that oral consumption of Annurca polyphenolic extracts
(AAE) stimulates hair growth, hair number, hair weight and keratin content in healthy human
subjects. Despite its activity, the analysis of the molecular mechanism behind its hair promoting
effect is still partially unclear. In this work we performed an unprecedented metabolite analysis
of hair follicles (HFs) in mice topically treated with AAE. The metabolomic profile, based on a
high-resolution mass spectrometry approach, revealed that AAE re-programs murine HF metabolism.
AAE acts by inhibiting several NADPH dependent reactions. Glutaminolysis, pentose phosphate
pathway, glutathione, citrulline and nucleotide synthesis are all halted in vivo by the treatment of
HFs with AAE. On the contrary, mitochondrial respiration, β-oxidation and keratin production are
stimulated by the treatment with AAE. The metabolic shift induced by AAE spares amino acids from
being oxidized, ultimately keeping them available for keratin biosynthesis.
Keywords: nutraceuticals; apple polyphenols; Procyanidin B2; anti-oxidants; hair growth
1. Introduction
During its life, a human healthy hair follicle (HF) undergoes cyclical rounds of growth, active fiber
production (anagen), degeneration (catagen) and rest (telogen) [1]. Anagen, the phase when hair shaft
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extension occurs, can last years in humans and is fueled by hair matrix cells (HMs) located in the hair
bulb (HB). These highly proliferating cells are stimulated by the dermal papillas (DP) to differentiate
into different lineages of cell including the outer (ORS) and inner (IRS) root sheaths, all differently
involved in the production, deposition, protection and hardening of keratins [1–4].
Patterned hair loss (PHL) affects around 50% of the adult population worldwide. Independent
of age and gender, this condition exerts a profound negative impact on some people’s quality of
life [4] and, especially when occurring at an early age, it is frequently associated to depression [5,6].
During PHL, HFs undergo a premature miniaturization and shorten their permanence in anagen.
The etiology of PHL is complex and involves a combination of genetic, psychological, and environmental
factors [7,8]. Only for Androgenic Alopecia, one of the most common cause of PHL, pathogenesis has
been partially elucidated and proven to involve an altered metabolism of testosterone [6]. The increased
activity of the type II isoform of the 5-α reductase enzyme (5AR) and the local level of its product
dihydrotestosterone, results in shortening of anagen phase and progressive miniaturization of the
HFs [9].
Finasteride (FIN), the only United States Federal Drug administration (FDA) approved oral agent
for PHL, is a specific inhibitor of 5AR type II isoform. Minoxidil (MIN), the other FDA approved
topical agent acts as potassium channel opener, apparently increasing follicular vascularity of the hair
DP, prolonging anagen and shortening telogen [10]. Considering the occurrence and the complex
etiology of PHL, it is widely accepted that new therapies have to be identified [11]. Moreover,
FIN and MIN activity reaches a plateau within two years of usage and both produce adverse effects on
patients [12,13].
In the past decade, an increasing number of reports have provided support for nutritional and
antioxidant therapies as effective and safe treatment options for hair loss. Dietary supplements like
those enriched in plant extracts [14,15], amino acids [16,17], vitamins [18] are popular over-the-counter
products and have indeed been shown to increase anagen rate in PHL patients. Nutraceuticals enriched
in Procyanidin B2, a dimeric procyanidin, have been recently shown to promote hair growth and
induce anagen in humans [19]. Malus pumila cv. Annurca, an apple native to Southern Italy, presents
one of the highest contents of Procyanidin B2 [20]. Recently we have published the results of a clinical
trial describing the effect of Annurca Apple polyphenolic extract of (AAE) on hair growth in healthy
subjects. A significant result in terms of increased hair growth, hair number, hair weight and keratin
content could be measured already after 2 months of oral treatment [21].
To date, despite the increased usage of nutraceuticals for hair growth, studies concerning their
mechanism of action are far from being complete. Nutraceuticals are supposed to generally act either
as antioxidants or indirectly by increasing vascularization, blood flow and nutrient supply to the
HFs, ultimately affecting their homeostasis and metabolism [22–25]. As for many other polyphenols,
the molecular mechanism underpinning AAE activity on HFs is still obscure. Moreover, the hundreds
of polyphenols contained in AAE [26] influence each other complicating the analysis of the intracellular
pathway influenced by the extract. In vitro, AAE stimulates proliferation of keratinocytes and induces
production of keratins [21]; in murine epithelial cells, pure Procyanidin B2 has been shown to inhibit
Protein Kinase C (PKC) isozymes [27] and modulate transforming growth factor Transforming Growth
Factor β [19,27–31].
To give new insights into the growth promotional effects exerted by AAE on HFs, we here
investigated the metabolomic profile of murine HFs treated with AAE. C57BL/6 mice received
a topical treatment with a cosmetic foam containing AAE. Upon 4 weeks of treatment, murine
HFs were extracted from the skin and their metabolome were analyzed by Direct Infusion Fourier
Transform-ion cyclotron resonance mass spectrometry (DI-FT-ICR-MS). This technique is characterized
by unmatched ultra-high mass accuracy and resolution, that make it highly suitable in metabolite
profiling [32]. Metabolomic approaches are extremely useful tools for probing any change in
metabolism accompanying drug treatments and provide invaluable insights in the mechanism of
action of complex mixtures and phytocomplexes [33]. Measuring the specific effect that AAE exerted
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on the metabolome of HF cells we can here show that the polyphenolic extract is able to stimulate
keratin production in HFs by shifting HF metabolism from aerobic glycolysis and glutaminolysis into
oxidative mitochondrial respiration.
2. Materials and Methods
2.1. Reagents
Chemicals and reagents used for metabolite extraction were all HPLC grade. Water was treated
in a Milli-Q water purification system (Millipore, Bedford, MA, USA) before use. The standards used
for the identification of intracellular HF metabolites were from Sigma Chemical Co. (St. Louis, MO,
USA). Haematoxylin and Eosin were provided by Bio-Optica (Milan, Italy). MitoTracker Red CMXRos
(M7512, Invitrogen, Carlsbad, CA, USA) used for ex vivo staining of mitochondria in skin biopsies
was reconstituted in DMSO and 1 mM stock aliquots were stored at −20 ◦C before use.
2.2. Nutraceuticals
Composition of AAE cosmetic foam: AnnurtriComplex (industrial procyanidinic extract of
Annurca apple PGI (Protected Geographical Indication) (Malus pumila Miller cv. Annurca) produced
by MB-Med (Turin, Italy)) 6% (w/v), water, glycerin, decylglucoside, polysorbate, maltodextrin,
potassium sorbate, sodium benzoate, silica. The Placebo foam was formulated identically but did not
contain AAE.
2.3. Animals
Wild-type C57BL/6 mice (7 weeks old, postnatal day 49) were used in all experiments to test the
effect of cosmetic foam containing AAE. All animals received human care and were maintained in
separate cages at 22–24 ◦C and fed a general rodent diet. Differently from other published protocols,
here animals were left unshaved and received a topical treatment with 2 cm3 of the indicated cosmetic
foam (this would correspond to 2–4 mL of foam for an adult human scalp) for 4 weeks, twice a week.
Only male animals were used in this study. All animal experiments were performed in compliance
with ethical guidelines and approved by the University of Naples Federico II.
2.4. Histology
After 4 weeks of treatments with AAE, mice were sacrificed and their dorsal skin immediately
excised and immersed in Phosphate Buffer Saline (PBS). 1 cm2 of skin biopsies were fixed overnight
in 4% formalin, washed in PBS, dissected and embedded in paraffin. 5–10 µm sections were
deparaffinised and stained with haematoxylin and eosin using standard procedures. For ex-vivo
staining of mitochondria, mice skin biopsies, immediately after excision, were rinsed in PBS and
located in six multi-well plates. The staining solution was prepared by diluting MitoTracker CMX-Ros
in Dulbecco Modified Eagle Medium (DMEM) (Invitrogen, Carlsbad, CA, USA) (without fetal bovine
serum) to yield a final concentration of 200 nM [34]. Tissues were incubated for 40 min in a Cell Culture
incubator at 37 ◦C, supplemented with 5% CO2. At the end of the incubation, tissues were rinsed three
times in DMEM, fixed in 4% formaldehyde (diluted in PBS pH 7.4), embedded in Paraffin or in OCT
and sectioned with a Leica 3200 Cryostat (Ramsey, MN, USA). 10–20 µm sections were washed in 96%,
90% and finally in 80% EtOH solution (5 min wash) to be then covered with a glycerol/PBS solution
1:1 (to avoid drying) and visualized under a fluorescent microscope using the following antibodies and
as already described [35]. When indicated sections were processed for immunofluorescence using the
following antibodies: anti-Keratin14 (cod. D14IF01918, Covance, Princeton, NJ, USA), anti-Keratine6
(cod. PRB-169P, Covance, Princeton, NJ, USA). Scanning Electron Microscopy (SEM) and Energy
Dispersive X-Ray (EDX) analysis of hair shafts were performed with a bench top Phenom XL (Alfatest,
Milan, Italy) following manufacturer instructions and as already described [36].
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2.5. Metabolite and RNA Extraction from Murine Tissues
Immediately after excision, tissues were rinsed and kept in PBS. Hair shafts were plucked out
with a sterile tweezers and immediately covered with a solution of PBS at R.T.(Room Temperature)
To allow detachment of HF cells, plunked HFs were incubated for 15 min in PBS supplemented with
5 mM EDTA. Hair shafts were removed with a cell strainer and HF cells were centrifuged for 5 min at
500 rpm. The cell pellets were washed twice in PBS and split in two aliquots. The first pool of cells
was solubilized in 1 mL of Trizol (Invitrogen, Carlsbad, CA, USA) and stored at −80 ◦C for qPCR
analysis [35]. The second pool was homogenized in 1 mL of pre-chilled methanol/water 1:1 solution
containing 10 nmoL of internal standard and finally centrifuged at 10,000× g for 10 min at 4 ◦C [37].
The resulting supernatants were collected and transferred into new Eppendorf tubes and stored at
−80 ◦C.
2.6. Mass Spectrometry-Based Metabolomic, Statistics and Analysis
Analyses were performed in direct infusion following a previous protocol [32,38] employing
a Hamilton syringe (250 µL) at a flow rate of 2 µL/min. Data were acquired on a SolariX XR 7T
(Bruker Daltonics, Bremen, Germany). The instrument was tuned with a standard solution of sodium
trifluoracetate. Mass Spectra were recorded in broadband mode in the range 100–1500 m/z, with an
ion accumulation of 20 ms, with 32 scans using 2 million data points (2 M). Nebulizing (N2) and
drying gases (air) were set at 1 and 4 mL/min, respectively, with a drying temperature of 200 ◦C.
Both positive and negative ESI (Electro Spray Ionization) ionization were employed. Five replicates of
each injection were carried out. The instrument was controlled by Bruker FTMS Control, MS spectra
were elaborated with Compass Data Analysis version 4.2 (Bruker, New York, NY, USA), identification
of compounds based on accurate MS measurements was performed by Compound Crawler version
3.0 and Metaboscape 3.0 (Bruker, New York, NY, USA). Metabolites signals were normalized using
internal standards. Comparisons and differences were analyzed for statistical significance by two-way
Anova test and Bonferroni post-tests analysis. All graphs, bars or lines indicate mean and error bars
indicate standard error of the mean (SEM). Furthermore, Partial Least Square Discriminant Analysis
(PLS-DA) was used as classification model. All graphs, bars or lines indicate mean and error bars
indicate standard error of the mean (SEM). Statistical analysis was performed using Statistica software
(StatSoft, Tulsa, OK, USA) and Minitab (Minitab Inc., State College, PA, USA).
3. Results
3.1. Topical Treatment with AAE Accellerates Exit of Murine HF from Telogen and Increases Keratin Content in
Hair Shafts
C57BL/6 mice were treated topically with a foam supplemented either with AAE (see methods
for details) or with a placebo. Foams were applied on the dorsal skin of 7-week-old mice. At the
beginning of the treatment, all the mice presented pink skins, indicating their HFs being in telogen [39].
After 4 weeks of treatment, mice (11-week-old) were sacrificed and their dorsal skin excised.
Skin biopsies were embedded in paraffin and prepared for histology. HFs were classified following
morphological criteria into the different stages of the hair cycle [40,41]. As expected, HFs of mice
treated with placebo were mostly in Telogen/Anagen I phase (Figure 1a,b). HFs appeared mainly
located in the dermis with only few DPs touching the subcutis border. Moreover, they appeared
fully surrounded by inter-follicular dermal fibroblasts and presented ORS but not IRS. Differently,
HFs of mice treated with AAE appeared increased in length and were located closer to the subcutis
(Figure 1c,d). Quantitation indicated HFs of mice treated with AAE being in Anagen, most of them in
Anagen II and few in Anagen III (Figure 1e).
To confirm HFs of mice treated with AAE being in a hair shaft production phase of the hair
cycle, keratin content and microstructure of the hair shaft sections closest to the HFs were evaluated
by SEM-EDX [36]. The percentage of Sulfur in the hair shaft was measured and correlated to the
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content of keratins (cystine, methionine, cysteine and cysteic acid are abundant amino acids of the hair).
Compared to placebo, AAE-treated hairs showed an increased content of Sulfur and thus of keratins
(Figure 1f–h). Since keratins are only produced by anagen HFs, our SEM data confirm histochemical
analysis indicating that AAE topical treatment accelerated exit of murine HFs from telogen phase.Nutrient  2018, 10, x FOR PEER REVIEW  5 of 16 
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Figure 1. AAE induces early exit from telogen and increases keratin content of hair shafts in murine
HFs. C57BL/6 mice were treated topically with a foam supplemented either with AAE or with a
placebo. Foams were applied on the dorsal skin of 7-week-old mice. After 4 weeks of treatment, mice
were sacrificed and HFs classified following morphological criteria. Haematoxylin-eosin staining of
HFs of mice treated with placebo (a–b) showing HFs mostly in Telogen/AnagenI phase. HFs of mice
treated with AAE appeared in a later stage of Anagen, mostly Anagen II (c–e). (f–h) SEM (SEM-EDX)
analysis of hairs extracted from mice treated with placebo (f) or with AAE (g). SEM quantitative
analysis indicates (h) an increase in Sulfur concentration (cystine, methionine, cysteine and cysteic acid
all abundant amino acids of hair keratins) in hairs of mice treated with AAE. Values in € and (h) are
reported as mean ± SEM (n = 8, *** p < 0.001). Scale bars in a-d correspond to 200 µm. Scale bars in (f)
and (g) correspond to 10 µm.
3.2. Topical Treatment with AAE Alters the Intracellular Levels of HF Key Metabolites
HF cells were plucked out of mice treated topically with AAE and their mRNAs analyzed by
quantitative Real-time qPCR. As shown in Figure S1, AAE reduces the expression of CD34, a marker
of quiescent, infrequently dividing, murine bulge stem cells [42]. Differently, AAE has less effect on
the transcription of Keratin 15, another marker of bulge stem cells and of Lgr5 a Wnt target gene.
Interesting GLI-1, that is barely expressed in HF cells treated with Placebo is strongly induced by
AAE [43]. GLI-1, is a marker of hair bulge and hair germ. Stem cells expressing GLI-1 have been shown
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to give rise to differentiated cells in all layers of the HF. The increased GLI-1 expression confirmed
AAE inducing exit of HFs from telogen, since GLI-1 positive cells have been reported to be the first
triggered at the onset of anagen [43].
The metabolic content of HF cells plucked out of mice treated topically with AAE were analyzed
by DI-FT-ICR mass spectrometry. qPCR analysis confirmed that most of the HFs cell lineages are
represented in our samples. It must be taken in account, however, that we cannot ascertain their
relative contribution to the metabolic analysis here presented.
Complex profiles were obtained in both positive and negative ionization. The high mass accuracy
(average: 0.166 ppm, Table S1), isotopic distribution and comparison with available standards, ensured
confident identification. As can be appreciated from Figure S2, showing the scores plot of PLS-DA
in both positive and negative ionization, a distinct separation between AAE-treated and Placebo
HF metabolomes can be observed. By screening for intracellular metabolites with similar alteration
tendency in all the AAE-treated mice, glutaminolysis, pentose phosphate pathway (PPP), amino acid
oxidation, mitochondrial β-oxidation and arginine metabolism became our focus.
In mammals, HF metabolism is mainly set on aerobic glycolysis and glutaminolysis [44]. Despite
the presence of oxygen and of functional mitochondria, HF cells obtain energy mostly by converting
glucose into lactate [44]. This product of cellular fermentation is secreted by HF cells and reaches
the liver (via the blood circulation) to be recycled back to glucose via the Cory cycle. We thus
started our metabolic profiling looking for statistically significant changes in the levels lactate, glucose
and related sugars. We measured a significant elevation in the intracellular levels of both glucose
(2.4 ± 0.1-fold, mean ± SEM, p < 0.001) as well as of the glycogen synthesis/degradation products
maltose (2.2 ± 0.2-fold, p = 0.032) and sorbitol (3.1 ± 0.1-fold, p < 0.001) (Figure 2a). On the contrary,
lactate levels were not significantly altered by AAE (1.1 ± 0.2-fold, p > 0.05) (Figure 2a).
This elevation in the intracellular levels of the glucose, maltose and sorbitol is compatible with
both a decrease and an increase in the rate of Glycogenolysis. However, since lactic acid, a product of
aerobic glycolysis, is not significantly altered by AAE, it is reasonable to suppose an inhibition rather
than of an induction of Glycogenolysis.
A considerable percentage of glucose and glutamine are usually oxidized in the HFs via the
PPP [44]. Similarly, to glucose, we measured a significant elevation of glutamine (2.4 ± 0.1-fold,
p < 0.001) in HF cells treated with AAE (Figure 2a).
We could as well measure an increase in the intracellular levels of the PPP intermediate ribulose
5-phosphate (ribulose 5P)/xylulose 5-phosphate (isobaric compounds, 3.2 ± 0.2-fold, p < 0.001)
suggestive of a reduced oxidation of glucose and glutamine via the PPP.
Matrix cells of the HFs have one of the fastest rates of cell division in the mammalian body.
PPP supports nucleotide biosynthesis in order to maintain their concentration sufficiently high to allow
DNA and RNA synthesis. Considering the increase in ribulose 5P, we were thus expecting a decrease
in the levels of nucleotides and deoxy-nucleotides. We indeed measured (Figure 2b) a decrease in the
intracellular levels of adenosine (0.40 ± 0.09-fold, p < 0.001), cytidine (0.6 ± 0.1-fold, mean ± SEM,
p value < 0.001), deoxy-cytidine (0.5 ± 0.1-fold, p < 0.001) and deoxy-inosine (0.45 ± 0.12-fold,
p value < 0.001). On the contrary, inosine (0.9 ± 0.1-fold, p < 0.05) and deoxy-adenosine (1.0 ± 0.1-fold,
p > 0.05) were not significantly altered by AAE (Figure 2b).
Similarly, to glutamine, also the intracellular level of glycine appeared increased upon treatment
with the polyphenolic extract (6.2 ± 0.2-fold, p < 0.001) (Figure 2c). Both glutamine and glycine [45]
inputs are rate limiting steps for the synthesis of the tripeptide (Glu-Cys-Gly) glutathione (GSH),
the main intracellular scavenger of Reactive Oxigen Species (ROS). Intracelluar levels of GSH
underwent a small but statically significant decrease (0.9 ± 0.1-fold, p < 0.005) in HFs treated with
Annurca Polyphenols (Figure 2c), further suggesting a reduced conversion of the two amino acids
in GSH.
The (i) significant elevation of glutamine and (ii) glycine, (iii) the increase in the intracellular
level of the PPP intermediate ribulose 5P together with (iv) the reduction of the intracellular levels of
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nucleotides and deoxy-nucleotides, all together suggest that AAE causes a reduction in the utilization
of glucose and glutamine for PPP, a metabolic pathway that in HFs, supports nucleotide biosynthesis.
The reduced intracellular level of GSH confirmed that the catabolism of glutamine is halted in
AAE-treated HFs.
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Figure 2. AAE diverts HF metabolic pathways from PPP and amino acid oxidation. Metabolomic
analysis (Carbohydrates (a); nucleotides (b); amino acids (c); carnitine derivatives (d)) of HF cells
extracted from C57BL/6 mice treated topically for 4 weeks with a foam containing AAE (red dots,
ANNURCA) or a Placebo (black dots PLACEBO). Each point represents the normalized intensity of the
metabolite (n = 15 measurements, mean ± SEM. Two way ANOVA and Bonferroni post-test analysis
were performed; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; n.s.: non statically different).
The effect exerted by AAE on the intracellular levels of glutamine and glycine reflects that
observed for other amino acids (Figure 2c). We measured an increase in the intracellular levels of
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arginine (1.3 ± 0.2-fold, p < 0.05), serine (1.3 ± 0.2-fold, p < 0.05), and lysine (1.3 ± 0.2-fold, p < 0.05).
Differently, the intracellular level of histidine (1.0 ± 0.1-fold, p > 0.05), tyrosine (1.0 ± 0.1-fold, p > 0.05),
leucine (0.9± 0.1-fold, p > 0.05) and phenylalanine (1.0± 0.1-fold, p > 0.05) were not statistically altered
by AAE. Interesting, glutamine and glycine are important component of hair keratins. The intracellular
increase in arginine correlates with a reduction in intracellular level of citrulline (0.7 ± 0.2-fold,
p < 0.05), but not of the other two arginine derivatives ornithine (1.1 ± 0.2-fold, p > 0.05) and creatine
(1.0 ± 0.1-fold, p > 0.05), whose levels did not change significantly (Figure 2c).
Overall, considering the results of our SEM data and the metabolite profiles we can suggest
that AAE diverts the intracellular metabolism of HFs from being mainly set on PPP and amino acid
oxidation, leaving a pool of selected amino acids ready to be used for keratin biosynthesis. Considering
that glycolysis and glutaminolysis are the main source of energy for hair bulb cells we went looking
for metabolites that could suggest a new source of energy compensating for the absence of glucose and
glutamine metabolism. Mitochondrial β-oxidation represents an alternative source of energy for HF
cells [46–48]. In AAE-treated HFs, we measured a significant decrease in the intracellular levels of the
β-oxidation substrate palmitoyl carnitine (0.8 ± 0.1-fold, p < 0.05) (Figure 2d) suggestive of an increase
in mitochondrial β-oxidation activity [49]. Similarly, we measured an increase in acetyl-carnitine
(Figure 2d) a metabolite enriched in cells with highly active mitochondria (1.6± 0.2-fold, p < 0.001) [49].
To further prove that the treatment with Annurca Polyphenols was indeed increasing
mitochondrial activity in HFs, we probed skin biopsies of mice topically treated with AAE with
the mitochondrial probe MitoTracker CMX-ROS. The fluorescence emitted by this dye correlates
with the membrane potential of the mitochondrial intermembrane space. The latter, depending
on the number of protons transported by the electron transport chain, is a direct measurement of
mitochondrial activity. The dye faintly stained HFs of mice treated with the foam containing the
placebo (Figure 3, upper panel), confirming, as already reported [46,47] a low mitochondrial activity in
telogen HFs [40]. On the contrary, in AAE-treated HFs, the fluorescence emitted by the dye appeared
much more intense, confirming an increased mitochondrial activity (Figure 3, lower panel). We could
visualize the fluorescence of the dye mostly in bulge cells and in ORS cells (Keratin 14 and Keratin 6
positive HF cells) and only rarely in those located in other regions of the HF.
Overall our metabolomic analysis reveal that glycogenolysis, glutaminolysis, PPP, glutathione
and nucleotide synthesis are all diminished in vivo by the treatment with Annurca Polyphenols.
On the contrary, mitochondrial respiration, β-oxidation and keratin production are stimulated by the
treatment with AAE. In the presence of this alternative source of ATP, HFs probably spare amino acids,
avoiding them from being oxidized, and keeping them available for keratin production.
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4. Discussion
Annurca Apples have shown their potential as nutraceutical in many biological contexts.
The plethora of specific and peculiar intracellular pathways activated by this cultivar seems to
depend on the high amount of Procyanidin B2 they contain. Annurca Apples polyphenols act
as antioxidant, modulate in vivo lipid metabolism and cholesterol levels and act against stress
and aging [20,50–52]. Despite the different biological system in which AAE resulted to be active,
the identification of the molecular mechanism underpinning its activity is far from being complete.
Addressing this question is not a simple task. The Polyphenolic fraction of Annurca contains hundreds
of different metabolites [26,53]. The activity of most of the polyphenols contained in AAE is drastically
reduced when they are isolated from the extract and used as pure molecules [54]. AAE phytocomplex
seems to represent the perfect environment where polyphenols can exert their biological function.
The phytocomplex probably acts chemically, by protecting apple metabolites from oxidation and
degradation. Recent evidences may suggest that the phytocomplex may as well act biologically by
activating and deactivating specific cellular pathways, ultimately augmenting the efficacy of the active
metabolites [54]. In this scenario, the need to follow hundreds of compounds simultaneously increases
the complexity of any study aiming at the identification of the mechanism of action of nutraceuticals.
Here, the use of an in vivo system and the metabolite profiles of HFs depicted by high resolution mass
spectrometry technique, allowed us to take a snapshot of some of the metabolic pathways activated
by Annurca polyphenols in HFs. We are, of course, not sure to have recovered by hair plucking all
the different cell lineages present in HFs. We have surely analyzed CD34, Keratin 15, Lgr5 and GLI-1
positive HF cells and thus covered most of the cell lineages present in telogen and early anagen [55]
However, their specific contribution to the full metabolic profile we here present is not possible to
determine. Clearly, the picture we obtained is not yet complete, but it is useful to explain some of the
hair growth promoting effects of Annurca Polyphenols.
Our metabolite profiling (Table 1) revealed that the topical treatment for 4 weeks with a cosmetic
foam containing AAE significantly changed the levels of at least 18 key intracellular metabolites.
The (i) significant elevation of glucose, (ii) glutamine, (iii) glycine, (iv) the increase in the intracellular
level of the PPP intermediate ribulose 5P together with (v) the reduction of the intracellular level
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nucleotides and deoxy-nucleotides all together suggest that AAE causes a reduction in the utilization
of glucose and glutamine for PPP, a metabolic pathway that in HFs, supports nucleotide biosynthesis.
Interestingly, all the reaction involved seems to share NADPH as cofactor. This electron carrier is
involved in many anabolic reactions including synthesis of ribose 5P, of nitrogen-containing bases
and of nucleotides. AAE probably affects the overall redox environment of the cell, affecting NADPH
production and redox potential. The reduction of the intracellular level of citrulline, the only catabolite
of arginine requiring NADPH for its production and the reduced intracellular level of GSH seems
to confirm and support our hypothesis that NADPH dependent reaction are halted in AAE-treated
HFs (Figure 4).
Table 1. Fold induction for the indicated metabolites measured upon in vivo treatment with AAE.
Metabolic Pathway Metabolite Fold Change 1 Metabolic Pathway Metabolite Fold Change 1
Glycolysis PPP
Glucose * 2.4 ± 0.2 Ribulose 5P * 3.2 ± 0.1
Lactic acid 1.1 ± 0.2
Glycogenolysis Nucleotides Adenosine * 0.4 ± 0.1
Maltose 2.2 ± 0.1 Cytidine * 0.6 ± 0.1
Sorbitol 3.1 ± 0.2 Deoxy-cytidine * 0.5 ± 0.1
Amino acids Deoxy-inosine * 0.5 ± 0.1
Glutamine * 2.4 ± 0.2
Glycine 6.2 ± 0.2 β-oxidation Palmitoyl-carnitine 0.8 ± 0.1
Serine 1.3 ± 0.2 Acetyl-carnitine 1.6 ± 0.2
Lysine 1.3 ± 0.2
GSH * 0.9 ± 0.1
Arginine 1.3 ± 0.2
Citrulline * 0.7 ± 0.2
1 (n = 15. Shown is mean ± SEM); * indicates metabolites requiring NADPH for their anabolism/catabolism.
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Figure 4. Topical treatment with AAE alters the murine HF metabolome. Schematic cartoon depicting
some of the metabolic reactions positively (green box) or negatively (red boxes) affected by AAE in
murine HFs. Red and green arrowheads indicate reactions halted or stimulated by AAE, respectively.
Red and green dots indicate metabolites whose intracellular concentration resulted decreased or
increased by treatment with AAE, respectively.
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Metabolic profiling reveals that, upon AAE, HFs engage in mitochondrial β-oxidation as indicated
by the reduced levels of one of its substrate palmitoyl-carnitine. Consistently we measured an increase
in acetyl-carnitine, indicative of high amounts of Acetyl-CoA in HFs. In Keratin 6 and Keratin
14-positive bulge cells we measured an increased mitochondrial membrane potential confirming the
activity of these organelles in AAE stimulated HFs. Mitochondria have been shown to contribute
to HF energy metabolism. Genetic disruption of the mitochondrial electron transport chain has
proven that mitochondrial function is essential for maintenance of HF. L-carnitine, which promotes
mitochondrial β-oxidation, favorably affects hair growth in vitro [48] and in vivo [47]. Mitochondria
are also important in follicle morphogenesis, because keratinocytes mitochondrial DNA depletion
decreases hair follicle density, increases apoptosis, and reduces proliferation. Moreover, stimulation of
mitochondrial function with thyroid hormones prolongs anagen and modifies intrafollicular keratin
expression [56–60].
We cannot be sure if the increase in mitochondrial activity induced by the AAE is “a consequence”
of the HF progression from telogen to anagen or if it is, on the contrary, “the reason” for the progression.
In support of the first hypothesis, a progressive mitochondrial hyper-polarization has been recently
shown in early anagen HF cells. This mitochondrial activity seems to increase in differentiating HF
cells and to abruptly reduce when differentiation is complete [46,55,61,62]. However, in support of the
second hypothesis, polyphenol have been in many contexts shown to directly affect mitochondrial
activity and stimulate mitochondrial ATP production. Both epicatechin and Procyanidin B2 possess
uncoupling effect on oxidative phosphorylation in cardiac mitochondria [63], suppressing activity
of pyruvate and malate oxidation and stimulating fatty acid β-oxidation. Comparing our metabolic
profiles with those described for murine HFs in different stages of the hair cycle [55], it seems more
likely that the mitochondrial activity itself is responsible for inducing the early anagen aspect of
AAE-treated HFs. More experiments will be needed to clarify this aspect.
Whatever the scenario, HFs treated with AAE are using the electron transport chain for producing
energy. Hair growth is a highly energy-consuming process [64,65], and the use of mitochondria for
ATP production probably helps sparing glutamine, glycine, and other important amino acids for
keratin production from being oxidized.
One puzzling point regards the Wnt inhibitory affect has recently been described for AAE
in human colon rectal cancer cells [54]. Wnt pathway activity is essential for HF morphogenesis
and regeneration [66]. Valproic acid and lithium chloride, all known Wnt inducers, promote hair
regeneration in murine models while the Wnt agonist Wnt7a is showing promising results in Phase I
human clinical trials [67,68]. Wnt agonists have been shown to be secreted by DP cells to initiate hair
stem cells to HF formation, as well as HM cells to initiate anagen [69]. In the process of becoming HM
cells hair stem cell engages in aerobic glycolysis, lactate production [55] and PPP to sustain the high
rate of proliferation they are subjected to. How does the Wnt inhibitory activity of AAE not interfere
with its hair-promoting effect in HFs? A simple explanation could be found considering the many
biological differences between colonocites and HFs. On the other hand, Wnt activity has been shown
to be only transiently activated during telogen to anagen transition [70,71]. We show that AAE reduces
the expression level of CD34, a marker of quiescent stem cells, while it does not alter the levels of the
Wnt target gene Lgr5. These preliminary results could point toward a scenario where Wnt inhibitory
activity of AAE contributes to the metabolic reprogramming of HFs by sustaining and accelerating
transition of quiescent stem cells into differentiated keratin producing cells [60–62].
All we have described must be added to the already proven antioxidant activity of AAE [20].
Oxidative stress has been shown to promote the catagen phase in HFs [72] and pro-oxidant effects
are suggested as the major mediators of smoking and ultraviolet light induced exacerbation of PHL
and Androgenic Alopecia [73]. AAE anti-oxidant potential is surely contributing to hair growth by
protecting HFs from environmental oxidative stress.
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5. Conclusions
While significant effort has produced a wealth of knowledge on the transcriptional and epigenetic
mechanism by which apple polyphenols exert their activity, little is known about the effect they
exert on metabolic pathways in vivo. Since there are essentially no published data on the effect of
polyphenols on the metabolic states of any cell in the HFs, a metabolomic study was necessary to
understand the effect of the extract and suggest a possible explanation for it. Together with their
already describe anti-oxidant potential we here show that AAE greatly affect mitochondria of HFs.
HFs stimulated by AAE engage in fatty acid β-oxidation to generate ATP, sparing amino-acid from
catabolism, ultimately igniting keratin production.
Supplementary Materials: The following data are available online at http://www.mdpi.com/2072-6643/10/10/
1406/s1, Figure S1: Effect of AAE on HFs measured by qPCR analysis, Figure S2: Partial least squares-discriminant
analysis (PLS-DA) of HFs metabolites determined by FT-ICR–MS, Table S1: Identification of metabolites in HFs
determined by DI- FT-ICR-MS.
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